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Clinical results of the application of a hemoglobin spray
to promote healing of chronic wounds
Klinische Ergebnisse zur Anwendung eines Hämoglobin-Sprays zur
Förderung der Heilung chronischer Wunden
Abstract
A new technological approach for supplying hypoxic chronic wounds
withoxygenisamoistwoundtreatmentwithaqueoussolutionscontain-
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patient uses) are presented, which were performed to create clinical Americo Villarreal
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3 dataregardingefficiencyandsafetyofthisproduct.Alldatahaveshown
that the application of the hemoglobin spray promoted wound healing
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Data from a clinical study in Mexico and subsequent therapy observa-
tions revealed that in 39 out of 42 patients (93%) the treated wounds
were healed. 9 patients from a series of therapy observations in 1 Department of Dermatology,
Charles University in Prague, Monterrey (Mexico) showed similar observations. All treated wounds
were closed. Single patient uses carried out in Witten (Germany; Third Faculty of Medicine,
Prague, Czech Republic 6 wounds from 8 (75%)) and Prague (Czech Republic; 5 wounds from
5 (100%) were healed) further support these results: The application
of hemoglobin spray can promote healing of chronic wounds.
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Within the framework of the clinical investigation, the treatment obser-
vations, and the individual healing experiments the hemoglobin spray
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wasappliedmorethan2,000timesontochronicwoundsof82patients.
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In all cases, the spray was well tolerated and there were no adverse
event that might have been an adverse reaction to the hemoglobin
spray.
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Zusammenfassung
Ein neuer technologischer Ansatz zur Versorgung hypoxischer chroni-
scher Wunden mit dem zur Heilung benötigten Sauerstoff ist eine
feuchte Wundbehandlung mit wässrigen Lösungen, in denen gut gewe-
beverträgliche Sauerstoff-Binder eine erleichterte Diffusion von Sauer-
stoffausderUmgebung(RaumluftauseineroffenporigenWundauflage)
zum Ulcus-Gewebe ermöglichen. Ein Produkt in Entwicklung enthält als
Sauerstoff-Binder Hämoglobin vom Hausschwein (Hämoglobin-Spray).
KlinischeUntersuchungen(eineklinischeStudie,Therapiebeobachtun-
gen und individuelle Heilversuche) werden präsentiert, aus denen sich
klinische Daten zur Wirksamkeit und Unbedenklichkeit ergeben.
Alle durchgeführten Anwendungen des Hämoglobin-Spray ergaben,
dass die Wundheilung gefördert wurde. In einer klinischen Studie und
einer unmittelbar nachfolgenden Serie von Therapiebeobachtungen
konnten bei 39 von 42 Patienten (93%) die behandelten Wunden
komplett geheilt werden. In gleicher Weise wurden die Wunden von
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terrey (Mexiko) bis zur Abheilung behandelt. Individuelle Heilversuche
in Witten (Deutschland; 6 von 8 Wunden (75%) abgeheilt) und in Prag
(Tschechische Republik; 5 von 5 Wunden (100%) geheilt) bestätigen
diese Ergebnisse: Anwendungen des Hämoglobin-Sprays können die
Heilung chronischer Wunden fördern.
Dabei wurden die Anwendungen des Hämoglobin-Spray ausnahmslos
gut vertragen, sämtliche beobachteten unerwünschten Ereignisse
während der Anwendungen hatten andere Ursachen.
ImRahmenderklinischenStudie,derTherapiebeobachtungenundder
individuellen Heilversuche wurde das Hämoglobin-Spray über 2.000-
mal in den chronischen Wunden von 82 Patienten angewendet. Es
wurde durchgehend gut vertragen, und es gab keine unerwünschten
Ereignisse, die verdächtig waren, möglicherweise unerwünschte Reak-
tionen auf das Hämoglobin-Spray zu sein.
Introduction
Reduced blood and oxygen supply to the skin and fatty
tissue beneath it are some of the aspects commonly as-
sociated with chronic wounds [1], [2], [3], which are al-
ways ulcerations (defective tissue wounds). Hypoxia can
be observed, in particular, in case of arterial occlusions
(PAOD),Diabetesmellitus(Dm)andchronicvenousinsuf-
ficiency (CVI) – these three diseases are the main cause
of90%ofchronicwoundswithaninternalwoundhealing
disorder. Possibly, tissue hypoxia is the common etiology
for pathological mechanisms underlying wound healing
disorders [4], [5], [6], [7], [8].
An overall positive effect on wound healing through im-
provement in its oxygen supply is undisputed today [4],
[5], [6], [7], [8]. Other recognized components for the
treatment of chronic wounds are surgical (vascular sur-
gery), medicinal (to improve local blood supply) and
technical(normobaricandhyperbaric,localandsystemic
oxygen treatments) methods in clinical application.
The wound healing processes demand a sharply higher
oxygen supply to the tissue so as to build up defenses
against pathogens (respiratory burst, formation of ROS)
[9] as well as to meet the increased metabolic demands
for physiologic wound debridement and replacement of
defectivetissuewithnewlydevelopinggranulationtissue.
These cell proliferation processes – including neo-vas-
cularization and production of new intercellular matrix
(in particular collagen synthesis) – require high levels of
oxygen [10].
One therapeutic possibility is to supply the wound bed
with the required amount of oxygen from outside. How-
ever, transudate and exudate excreted into the base of
the wound from the exposed tissue, form an effective
barrier for the diffusion of oxygen into the tissue in the
region of the wound bed. Moist wound treatment is cur-
rently the recognized treatment standard especially for
chronic wounds, since the healing of wounds is hindered
when they dry up [1], [2], [3]. For the moisture to remain
in the wound bed, the diffusion barrier must be removed
– at least partly. This is made possible using a concept
byBarnikoletal.[11]–e.g.withoxygentransportersthat
are brought onto the wound bed in aqueous solutions.
The oxygen transporters clearly augment diffusion of
oxygen by facilitated diffusion. However, these oxygen
transportersshouldnothinderthewoundhealingprocess
in any way and be non-toxic to cells. Hemoglobin taken
from mammals is well suited as a transporter and, since
itissoluble,canalsotransportoxygenmoleculesoutside
the erythrocytes. Moreover, it can be obtained cheaply
andinalmostunlimitedquantitiesfromslaughteranimals
intended for human consumption, it is naturally present
in large amounts in animal bodies and is definitely not
intrinsically toxic.
The preparation of this solution includes hemoglobin ob-
tained from domestic pigs, as this hemoglobin does not
pose any considerable or even life threatening health
risks – for instance, pigs do not suffer from any prion
diseases (TSE). This pig hemoglobin solution can be
sprayed onto wounds (hemoglobin spray).
Clinicalresultsobtainedtodatearepresentedbelowand
are the basis for discussion with respect to the efficacy
of the hemoglobin spray.
Methods
Hemoglobin spray
Hemoglobin spray is an aqueous liquid preparation
(solution)containingpighemoglobin.Thisissprayedonto
the wound bed following wound cleansing and is covered
withathin,nanofiberwounddressingwhichispermeable
to air. The hemoglobin contained in the spray supplies
the tissue at the wound bed with oxygen over a long
period of time through diffusion [11].
The hemoglobin spray has a purely physical effect on the
wound and does not contain any medicinally effective
constituents.
Indications for use
Indications for the application of the hemoglobin spray
include chronic wounds (ulcers) of the skin, crural ulcers
(Ulcuscruris)ofvenous,arterialormixedgenesis,diabetic
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pressure ulcers.
There are some medical prerequisites for application of
the spray. The causative disorders and conditions lege
artis must be treated: improvement of venous backflow
through surgical sensitization or compression therapy,
thepossibilityofsurgicalsensitizationofchronicwounds
of arterial origin, regulation of blood sugar level, release
of pressure from amputation stumps, decubitus wounds
etc.
Patients should not be allergic to any of the spray’s con-
tents or animal proteins.
Optimally, wounds should not exceed 35 cm
2, but their
depth may reach deeper than the papillary dermis.
Hemoglobin spray must not be used on wounds in con-
junction with other topical therapeutic medications or
woundantisepticssincetheymightreactwitheachother.
Scheme of application – wound
conditioning and use of hemoglobin
spray
Thewoundwerecleansedasthoroughlyaspossibleprior
toapplicationofthehemoglobinspray(removalofadher-
ent deposits and crusts could take some days) so that
the wound bed was laid free and the spray could come
into direct contact with the sub-ulcerous tissue. After the
wound bed was dried out using an absorbent cloth, the
hemoglobin solution was sprayed in a thin layer (Figure 1
shows an example) and the wound was covered with an
open-porous dressing. The spray was generally applied
initiallyifpossibleondailybasisandifthewoundhealing
process shows good progress, treatment intervals were
lengthened (e.g. to every second or third day).
Figure 1: A chronic wound (a) after debridement and (b) after
application of the (intensive red colored) hemoglobin spray
Patients and wound treatments
Patientsandtheirwounds,aswellasdeviationsfromthe
general application scheme as described above can be
found in the following chapters of the different treat-
ments.
Clinicaltrialandtreatmentobservations
in Ciudad Victoria (Tamaulipas, Mexico)
In Cd. Victoria, capital city of the Mexican province of
Tamaulipas, the health minister (Secretaria de Salud) in
the province's government (Gobierno de Tamaulipas)
carried out a clinical trial to determine the efficiency of
hemoglobin spray treatment of chronic wounds in lower
leg region.
The trial consisted of a clinical comparison between a
groupofpatientswhoweretreatedwithhemoglobinspray
and a second group who received on-the-spot treatment
with a method common in the region (“moist” wound
treatment through water-impermeable occlusion of the
wound surface with Vaseline° after intensive antisepsis,
followed by use of a sterile bandage).
The total number of patients included in the study was
28 (see below).
The patients were randomly assigned to each of the two
groups. The primary end point of the study was the time
at which the chronic wounds healed completely.
The study type was prospective and longitudinal, mono-
centric and open-label, wounds were at least 8 weeks
old and had until then been unsuccessfully treated using
common local therapeutic methods, participation in the
studywasonavoluntarybasis.Allpatientswereinformed
about it and agreed with it, patients were randomly as-
signed to either of the two groups, diagnosis of vascular
function by determining venous backflow (color Doppler
sonography), venous refilling time using the “muscle
pump” test (quantitative photoplethysmography), ankle
brachial pressure index (ABI) as well as ischemic hypoxia
through peri-ulcerous measurements of transcutaneous
oxygen tensions.
The inclusion criteria were age over 20 years, wounds
localized in the distal lower leg region (ankle region), ad-
equate therapy of causative diseases, a wound surface
of less than 35 cm
2, local restriction of an inflammation,
and depth of wound not deeper than the subcutis (grade
2 or 3 according to Daniel [12]).
The exclusion criteria were known allergy against any
componentofthehemoglobinspray,alocalmacrovascu-
lar obstruction of the leg, severe lipodermatosclerosis,
eroded wound borders, a severe systemic disease,
smokingofover20cigarettesdaily,alcoholordrugabuse
as well as pregnancy.
After six months an intermediary evaluation of the com-
parative study was conducted, and due to the distinct
positive results the study was closed.
The verum group was treated according to the general
application scheme for hemoglobin spray (see above),
and the traditional treatment consisted of antisepsis of
the chronic wound and mechanical debridement by con-
secutive rubbing the wound bed with cotton pads im-
mersed with 2 different antiseptics (benzalconium chlor-
ide, 0.12% and iodine solution, 0.8%), occlusion of the
wound with a thin layer of Vaseline° (pharmaceutical
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pads every second day.
All patients with wounds that had not healed after the
first 6 month were now further treated with hemoglobin
spray and therapeutic observations were conducted
without involvement of a control group (not controlled).
In this part of the study, some additional patients were
brought in who had wounds that did not meet the inclu-
sion criteria for the comparative study.
In this way, the number of patients treated with hemo-
globin spray increased to 42.
Therapeutic observations in Monterrey
(Nuevo Leon, Mexico)
InMonterrey,patientsweretreatedataprivate(commer-
cial) wound clinic (Clinica Sangui) using a hemoglobin
spray that had been provisionally allowed in Nuevo Leon
at that time. The severity of the wounds and the duration
of the treatment varied largely.
The results of the treatment of 9 patients were docu-
mented completely in detail.
Thefollowingwoundsweretreated:4Ulcuscrurismixtum,
from which 1 with Diabetes mellitus and 2 with arterial
hypertension, and 5 Ulcus cruris venosum, from which 1
with Diabetes mellitus. All 9 patients suffer from long
term chronic venous insufficiency.
All 9 patients' wounds had existed for several months or
evenafewyears(onaverage144weeks,varyingbetween
45 and 312 weeks).
Treatments were carried out following the general appli-
cation scheme as described above.
Single patient uses at the University of
Witten/Herdecke in Witten (Germany)
InWitten,thefollowingpatientsandtheirvaryingwounds,
which had been classified as “therapy resistant” or even
as “untreatable” after analysis carried out by their previ-
ousphysician,weretreatedinvarioussinglepatientuses.
• m., 39 yrs: chronic wounds in amputation section of
the forefoot (left) according to Lisfranc after an plastic
acc.toEmmert(nailwedgeexcision)oftheleftbigtoe,
PAOD Stage 4 (according to Fontaine),
• f., 83 yrs: chronic Ulcus cruris mixtum (ulcer of the
medialankleoftheleftfoot)inCVIandPAOD–Stage2
• m., 71 yrs: stagnant flat Ulcus cruris (ulcer of the right
calf, lateral) in a Papillomatosis cutis lymphostatica
(stasis dermatitis with eczema) with primary lymph
edema
• f., 54 yrs: Ulcus cruris venosum (ulcer of the medial
ankle of the right foot) in CVI with dermoepidermitis
since several years
• m., 78 yrs: Ulcus cruris venosum (ulcer of the lateral
ankle of the right foot in an old surgical scar) in CVI
and PAOD – Stage 4
• f.,66yrs:chronicUlcuscruris(ulcerofthelateralankle
of the left foot) in CVI over a stiffened ankle joint (left
leg paralyzed and shortened since birth), in addition
local arteriovasculitis
• f.,52yrs:therapyrefractorymedialmalleolarulceration
(left.)inCVI,MorbusRaynaudandrheumaticcollagen-
osis
• f., 70 yrs.: Ulcus cruris (ulcer of the medial ankle of
the right foot) in a region of marked dermatoliposcler-
osis, recurrent over several years.
The patients were treated according to the general appli-
cation scheme as described above with minor individual
deviations, because the scheme was developed in the
first place with these patients.
Single patient uses at the University
Dermatology Department in Prague
(Czech Republic)
In Prague, individual healing trials were carried out on
5 patients at the Charles University Dermatology Depart-
ment using hemoglobin spray, with the support of a re-
searchgrantprovidedbytheHealthMinistryoftheCzech
Republic, No. IGA NS/10093-3. During wound treatment
under a thin wound dressing made of nanofibers and
permeable to air, treatment with hemoglobin spray was
also carried out according to the recommended mode of
application.
All patients who were treated here were men, at least
65 years old (65, 69, 70, 71, and 74 years), were being
treated for Diabetes mellitus over several years and had
chronic wounds in the lower leg. The wounds had existed
for at least 9 months and, in case of patient No. 4, the
wound existed for 3 years without showing any tendency
to heal. Treatment of the chronic wounds thus far carried
out had followed the current therapy standards.
Thehemoglobinspraywasimplementedasanadditional
stepintheroutinewoundcareprotocol.Afterappropriate
wounddebridementandwoundantisepsisthespraywas
applied. As wound dressing, in all cases an open porous
polyurethane foam dressing was used. Patients were
treated once daily, 5 days a week.
Results
Clinicaltrialandtreatmentobservations
in Ciudad Victoria (Tamaulipas, Mexico)
In Cd. Victoria, capital city of the Mexican province of
Tamaulipas, the health minister (Secretaria de Salud) in
the province's government (Gobierno de Tamaulipas)
carried out a clinical trial to determine the efficiency of
hemoglobin spray treatment of chronic wounds in lower
leg region.
A set of data regarding disease status and epidemiology
ofpatientsincludedinthestudyorsubsequenttherapeut-
ic observation was generated summarized in Table 1.
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Figure 2: An example of a chronic wound at the beginning of the therapy (a), during treatment (b) and after healing (c) (Pat.
11-MMAA)
Figure 3: Second example for a chronic wound at the beginning of the therapy (a), in course of the treatment (b) and after
healing (c) (Pat. 05-PCM)
After about 6 months 14 patients were taken into each
of the two groups and treated accordingly. In the hemo-
globin spray group the chronic wounds of 13 patients
(93%) healed, whereas in the control group the wounds
of only one patient (75%) were healed.
Due to the positive results achieved by the hemoglobin
sprayintheintermediaryevaluation,aftersixmonthsthe
comparative study was discontinued and switched to
therapeutic observations.
Through treatment with hemoglobin spray, the wounds
completely healed for 39 of the 42 patients. From the
3 patients whose wounds could not heal, two had vascu-
litis and the other one had osteomyelitis.
Only 2 patients, who were discharged after complete
healingoftheirwounds,developedarecurrenceoflesions
inthesameregionduetovenousinsufficiencyandsocial
negligence.
Figure 2 and Figure 3 show examples of wound healing
by initial, intermediate and final pictures of wounds of
2 patients (encoded with: 11-MMAA-H, and 05-PCM-V).
Within the framework of the clinical investigation carried
out at the Hospital Civil de Cd. Victoria, the hemoglobin
spraywasappliedalmost1,500timesonchronicwounds.
In all cases, the spray was well tolerated and there were
no undesirable events that might have resulted due to
the application of the hemoglobin spray.
Therapeutic observations in Monterrey
(Nuevo Leon, Mexico)
In Monterrey, patients with chronic wounds were treated
using the hemoglobin spray that had been provisionally
allowed by local authorities in Nuevo Leon for this pur-
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Table 3: Duration of selected wound before treatment in Witten (weeks), number of treatments with hemoglobin spray at the
University in Witten and total duration of treatment until complete healing of chronic wounds (weeks)
pose. The severity of the wounds and the duration of the
treatment varied largely.
All wounds of the 9 patients with a completed documen-
tation were completely healed after a few weeks of ther-
apy (on average 10.8 weeks, varying between 4.0 and
19.7 weeks).
Table 2 shows the number and duration of treatments
performed to reach the clinical results.
Even wounds which were present for more than 3 years
(156, 210, 260, and 312 weeks) were healed within less
than about 15 weeks of treatment.
Thenumberofdocumentedcasesinwhichthespraywas
applied totaled 231 – altogether, 24 patients were indi-
vidually treated around 48 times with hemoglobin spray.
A total of 9 adverse events were reported in 2 patients.
In none of these cases, a local inflammation, local or
generalizedallergicreaction,skinirritation,burning,pain
or maceration of skin were reported that might have had
anundesiredeffectofsuspiciousnature.Thephotograph-
ic documentation of the observations in the course of
treatment also depicts good tolerability for the product.
Single patient uses at the University of
Witten/Herdecke in Witten
The chronic wounds of the first 6 patients (75% of all
patients) could be healed through application of the
hemoglobin spray.
The wounds existed for 71.7 weeks on average (varying
between 6 and 234 weeks) and were healed after treat-
ment with the hemoglobin spray (after 16.6 weeks on
average, varying between 1.9 and 31.8 weeks). Table 3
summarizes the results.
The 1
st patient turned out to be intermittently unco-
operativeand,duringhistreatment,avoidableworsening
of his wounds occurred, besides the fact that his treat-
ments were interrupted for a 13 week period. Hence,
thesetimevalueswerenotusedtocalculatetheaverage
value.
The 2
nd patient, who lived around 45 km away, was alter-
nately treated conventionally (moist wound padding) by
a local community nurse.
The initially presented wound of the 6
th patient healed
after 74 treatments (76 days), but the scarred skin lying
distally to the initial wound, in an area of pronounced
Atrophie blanche, died off (through immunological oblit-
eration?) rapidly (within a few days) and fell off in a moist
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(second, slightly larger) wound lasted till the 219
th day.
These results obtained from single patient uses carried
out on chronic wounds of varying genesis also clearly
prove the efficacy of hemoglobin spray.
With regard to the safety of the use of hemoglobin spray,
no adverse events were observed in any of the 276 ap-
plications in which the spray was applied on 8 patients
(applied 150 times on one patient).
Single patient uses at the University
Dermatology Department in Prague
The results of the treatment on the 5 patients in Prague
also showed a positive influence on the healing of
chronic wounds. In all five cases healing of the wounds
treated with hemoglobin spray was observed within a
time period of 8 to 12 weeks. Positive changes in the
wounds could already be observed within the first two
weeks following the start of the therapy. By the 3
rd to 5
th
week there were clear signs of healing. Due to the treat-
ment with hemoglobin spray, 3 of the 5 patients were
discharged from the therapy after 8 weeks, while the
two other patients had complete wound closure after
12 weeks.
Regarding compatibility, no allergic reactions or other ir-
ritations were observed. There was no pain when the
spray was applied. All patients were very satisfied with
the treatment.
Irrespective of the statistically small number of patients
treated in this case, the observations here also show an
effectiveness and good tolerability of treatment with
hemoglobin spray.
Discussion
Oxygen is of utmost importance in the healing of acute
and chronic wounds. Various studies have shown that
oxygen is involved in all steps of wound healing including
inflammation, granulation, neo-angiogenesis, re-epithel-
izationandtissuemodeling[5].Thereforeitisnotsurpris-
ing that reduced oxygen supply is a major driver of
pathogenesis of chronic wounds. As in many cases, oxy-
gendeliveryisdisturbedduetoalterationsinthevascular
system(artheriosclerosis/micro-ormacro-angiopathies/
venous hypertension) leading to a hypoxic wound envir-
onment. In particular, chronic wounds are maintained
due to this hypoxic status of the surrounding tissue.
Several therapies have been proposed to improve the
hypoxic status of tissues.
Hyperbaric oxygen therapies (HBOT) have shown to be
effective. But, it seems to be important that the vascular
system is functional and therefore HBOT may be less ef-
fective in the degenerated tissue of chronic leg ulcers
[13].Nevertheless,hyperbaricoxygentherapyisbecoming
an accepted treatment due to an increasing number of
studies showing potential mechanisms of action, in par-
ticular as an adjunctive therapy.
Heng et al. [14] compared topical oxygen therapy with
the standard treatment for necrotic gangrenous wounds
lacking blood supply. Forty patients were included in the
study, and 90% of patient ulcers that received topical
HBOhealedcomparedwith25%ofpatientulcerstreated
with standard wound management therapy. No oxygen
reperfusion damage was noted. The authors also
demonstrated that the ulcers treated with topical oxygen
had increased angiogenesis in the wound bed.
An alternative and attractive, while easy to handle, ap-
proach is the topical oxygen delivery or conveyance of
oxygen via a transport system. Although several different
topical oxygen delivery systems have been described for
wound healing, most of them revealed only poor results
in clinical trials. This may be due to inadequate delivery
of oxygen across the wound base exudate layer, which
actsasanoxygendiffusionbarrierandpreventssufficient
supply of oxygen to fibroblasts, keratinocytes and inflam-
matory cells necessary for wound healing.
Theapproachtofacilitateoxygendiffusionbyatransport-
er molecule like hemoglobin generated the possibility to
enable a constant supply of oxygen to the wound bed
after topical application of the hemoglobin spray to the
wound. The evaluation of the clinical data summarized
above showed a clear improvement of wound healing in
termsoftimeandquality.Withmorethan50documented
cases analyzed, patients with a long treatment history of
thechronicwoundwerereleasedfromtherapywithclosed
wounds. Therefore, the use of hemoglobin to facilitate
oxygen diffusion seems to be an ideal way to increase
the oxygen supply to the wound bed and, as a result, en-
hancing the underlying wound healing processes. This is
supportedbytheobservationsoffastonsetofproliferative
processes,inmanycaseswithinthefirst2–4weeksafter
first application of hemoglobin to the chronic wound.
All treatments using hemoglobin spray have shown that
the healing of wounds was promoted and in many cases
evenaccelerated.TheclinicalstudycarriedoutinCiudad
Victoria – aimed at getting hemoglobin spray approved
in Mexico – with its focus on a homogeneous range of
lower leg wounds and criteria set for the inclusion and
exclusion of patients has produced a very clear result:
The healing of chronic lower leg wounds in 93% of the
verum group in contrast to 7% in the control group in the
initialclinicalcomparativestudyprovesaclinicalefficacy
which goes well beyond the asserted objective of healing
chronic wounds.
Thedecisionoftheauthoritiestodiscontinuedeprivation
of the patients in the comparison group from the hemo-
globin spray on ethical grounds is clear proof that the
clinical efficacy of the spray lies well above the efficacy
of conservative treatment methods carried out in the re-
gion.
The study was opened ahead of schedule since it was no
longer considered ethically acceptable for the personnel
inchargetodeprivethepatientsinthecomparisongroup
from a clearly better form of treatment (with the hemo-
globinspray).Inessence,thestudyresultedinaresound-
ingaffirmationoftheefficacyofhemoglobinspray(which
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Mexico).
Follow-up therapeutic observations (with a widened
spectrum of chronic wounds) confirmed this outcome:
Almost all wounds could be healed through treatment
with hemoglobin spray.
The success rate for all patients amounted to 93% (39
out of 42 patients) at the end of the treatments. Both
results – the result of the comparative study as well as
the overall result – revealed the same picture: Through
treatment with hemoglobin spray, more that 90% of
chronic wounds could be treated.
The therapeutic observations in Monterrey (Mexico) and
the individual healing trials carried out in Witten (Ger-
many) and Prague (Czech Republic) also support the
overall result. The application of hemoglobin spray pro-
motes the healing of chronic wounds.
Regarding tolerability, hemoglobin spray was always well
tolerated and all the adverse events that were observed
inthecourseofthetreatmentshadothercauses.Adverse
events/reactions include, in particular, allergic reactions
of the patients against animal hemoglobin. However, no
suchallergicreactionswereobservedinover2,000cases
where the spray was applied on 65 patients. Currently,
there is no evidence of limited tolerability of hemoglobin
spray.
Conclusion
As described for the recent case studies in Prague, the
only change of treatment regimen was to add the hemo-
globin spray in the daily wound care routine. Therefore,
the use of the hemoglobin spray can be perceived as a
simple implementation in an existing wound care man-
agement procedure, but without any major changes of
the established protocol – as the aqueous solution con-
tains no further ingredients interfering with the wound
healing process.
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